Page 106 - 71_02
P. 106
MARÍA CASCALES ANGOSTO AN. R. ACAD. NAC. FARM.
(25) BARESE, C. N.; GOEBEL, W. S.; DINAUER, M. C. (2004): Gene therapy for chronic
granulomatous disease. Expert Opin Biol Ther. 4, 1423-34
(26) GOEBEL, W. S.; DINAUER, M. C. (2003): Gene therapy for chronic granuloma-
tous disease. Acta Haematol. 110, 86-92
(27) QUINN, M. T. Y GAUSS, K. A. (2004): Structure and regulation of neutrophil
respiratory bust oxidase: Comparison with nonphagocyte oxidase. J Leukocy-
te 76, 760-781.
(28) MILLER, F. J. JR. Y GRIENDLING, K. K. (2002): Functional evaluation of nonpha-
gocyte NAD(P)H oxidase Methods Enzymol 353, 220-233
(29) PACLET, M. H.; COLEMAN, A. W.; BURRITT, J. Y MOREL, F. (2001).NADPH oxidase
of Epstein-Barr-Virus immortalized B lymphocytes. Effect of cytochrome
b558 glycosylation. Eur J Biochem 208, 5197-5208.
(30) RAO, P. V.; MADDALA, R.; JOHN, F. Y ZIGLER, J. S. JR. (2004): Expresion on
nonphagocytic NADPH oxidase system in the ocular lens. Mol Vision 10, 112-
121
386
